Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
2.50
Ask:
2.80
Spread: 0.30 (12.00%)
Market Cap: £4.56m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Director/PDMR Shareholding

16 Oct 2018 11:14

RNS Number : 2005E
Nanoco Group PLC
16 October 2018
 

16 October 2018

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

 

Director Share Purchase

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, received notification today that Brian Tenner, Chief Operating Officer and Chief Financial Officer, purchased 158,543 ordinary shares of £0.10 each ("Ordinary Shares") in the Company on 16 October 2018 at a price of 32.0p per Ordinary Share.

Following this transaction, Brian has a beneficial interest in 158,543 Ordinary Shares, all of which are directly held. This interest represents approximately 0.055 per cent. of the total voting rights in the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 1

 Details of the person discharging managerial responsibilities/person closely associated 

a)

 Name

Brian Tenner 

 

2

Reason for the notification Purchase of Ordinary Shares

a)

 Position/status

Chief Operating Officer & Chief Financial Officer

b)

 Initial notification/Amendment 

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 Name 

Nanoco Group plc

b)

 LEI

England & Wales Company Number: 05067291 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

 Description of the financial instrument, type of instrument

Ordinary Shares

 

Identification code

NANOISIN GB00B01JLR99 

b)

 Nature of the transaction

Acquisition of Ordinary Shares 

c)

 Price(s) and volume(s)

 

Price(s) 32.0pVolume(s) 158,543 

d)

 Aggregated information

 

Price(s) 32.0pVolume(s) 158,543 

e)

 Date of transaction

16 October 2018 

f)

 Place of transaction

London Stock Exchange 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

 

Brian Tenner, Chief Operating and Financial Officer

 

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

 

 

Peel Hunt

Tel: +44 (0) 20 7418 8900

Adrian Trimmings

 

George Sellar

 

Guy Pengelley

 

 

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

 

nanoco@mhpc.com

 

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKADDKBDDDKD
Date   Source Headline
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jul 20242:14 pmRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:01 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:00 amRNSYear End Trading Update
1st Jul 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSBlocklisting Six Monthly Return
31st May 20245:19 pmRNSTotal Voting Rights and Share Capital
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.